Global /China /Healthcare /Drug Manufacturers - General /301065
chevron_leftBack
Zhejiang Benli Technology Co., Ltd. logo

Zhejiang Benli Technology Co., Ltd.

301065
SHE: 301065 Delayed
24.33CNY -0.7%
3.60 USD
As of 18 June 2026, Zhejiang Benli Technology Co., Ltd. has a market cap of $373.87M USD, ranking #17187 globally and #5355 in China. It ranks #1556 in the Healthcare sector, and #561 in the Drug Manufacturers - General industry.
Global Rank
17187
Country Rank
5355
Sector Rank
1556
Industry Rank
561
Key Stats
Market Cap
$373.87MUSD
2.53B CNY
Enterprise Value
$281.09MUSD
1.9B CNY
Revenue (TTM)
$94.48MUSD
638.51M CNY
EBITDA (TTM)
$21.3MUSD
143.91M CNY
Net Income (TTM)
$10.98MUSD
74.18M CNY
EBITDA Margin
23%
Profit Margin
12%
PE Ratio
34.6
PS Ratio
4.0
PB Ratio
1.8
EV/EBITDA
13.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Zhengjie Wu open_in_new
Employees
589
Founded
2011
Website
benlitech.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.7% 3.8% 7.6% 4.9% 5.5% 20%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
301065
浙江本立科技股份有限公司 Class A
ISIN: CNE100004RL8
Shares Out.:
103.173M1
TV:
SA:
YF:
GF:
BA:
MS:
24.33 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Zhejiang Benli Technology Co., Ltd.

Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride, 2,4-Dichlorofluorobenzene, and Methyl 3-methoxyacrylate; and Ethyl N,N-dimethylaminoacrylate, 2,6-Dichlorofluorobenzene, and 3-(2-Ethylene Glycol Methyl Ether)-2-Methyl -4-Methanesulfonyl benzoic acid. The company was founded in 2011 and is based in Linhai, China.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$53.99B
364.89B CNY
14K%
44.9
603259
$49.77B
336.36B CNY
13K%
17.2
$28.52B
223.48B HKD
8K%
35.7
$18.8B
147.32B HKD
5K%
162.3
$16.56B
111.89B CNY
4K%
-
9926
$16.01B
125.46B HKD
4K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
204K%
38.1
JNJ
$547.28B
146K%
26.4
ABBV
$360.63B
96K%
97.4
$323.08B
256.25B CHF
86K%
19.9
AZN
$289.5B
215.59B GBP
77K%
27.6
NOVN
$275.99B
218.9B CHF
74K%
20.5
chevron_leftBack